Member Info for Hazbeen

From other chat BB

From 3 mins onwards

Fascinating and informative interview showing how much potential is in the pipeline as well as nasal disinfection

Must listen , be patient as gets better

Ends at 50 mins

38 mins - spent £250m developing this major breakthrough protocol treatment , become standard of care globally

Compare that with £2.5 billion to develop an antibiotic

Get phase 3 granted , talking millions of patients who will using this

Talks about Vancouver and NHS hospital take ups too

https://youtu.be/hIKXAqkDKo8?si=qjkhibAwKPUl4tnN

Shedding light on the invisible enemy, Dr. Nicholas Lobel reveals the illuminating potential of photodisinfection to transform healthcare. Dr. Loebel serves as President and Chief Technology Officer (CTO) of Ondine Biomedical. Beyond the growing ineffectiveness of antibiotics, Dr. Loebel delves into the brilliance of using light to zap harmful microbes. Get ready to nerd out with the guys as they learn about how photodisinfection targets bacteria with laser-like precision on various surfaces and even within body cavities (right up the ol' schnoz), distinguishing itself from other light-based treatments. Dr. Lobel highlights the critical role of nasal decolonization in preventing hospital-acquired infections, showcasing impressive success stories and the untapped potential of this approach.

He only added 250k this time around

Double your money or lose all your money

High risk , Not for widows or orphans as the saying goes

Another bunch of crooks

Rife corruption in India.

There is another old stock , MPL , also run by corrupt Indian BoD that has been decimated over the years

Companies listed on the market to siphon off money from investors

Ronald,

Have to considered this share could be suspended if further criminal activities are found. We have no idea if there will be any consequences on balance sheet. It is way to risky now, best to wait to find out the outcome

Someone warned my alot of corrupt activities goes on with Indian companies, and have been proved to be right here

Good luck with that if the share is suspended

Risk is too high

Would touch these until there is a resolution one way or another

Get out !!!

Ronald ,

Worth reading points 8-10 on page 3, mentions the investigations by ED and also mentions something about buybacks made

bse bas results out for quarter , for some reason looks like much lower profit this quarter .

https://tinyurl.com/5xsb85cz

Ronald , bse bas results out for quarter , for some reason looks like much lower profit this quarter .

https://tinyurl.com/5xsb85cz

Ppl tend to hold onto loss makers , market is not always right, but is a lot of the time

One of the worst performing shares I have seen , and you see Dave50 is in disbelief and keeps comparing it to incomparable shares

Emotional about a share will be one’s downfall

Https://www.thehindu.com/news/national/tamil-nadu/ed-seizes-836-cr-from-premises-linked-to-opg-group/article68864941.ece

The story is getting out

Funding concluded at £8.8m net

Not a share to trade buy and hold for next 12 months to gain profits

Keep adding on any weakness

Phase 3 will now start after funding some

Long term funding will also get done

Glad to see only £8.5m done @8.5p

The rest will be alternative I expect and some has already been raised at 12.5p

If you look at the numbers being mentioned

Only estimate we can try and use is to multiple the current hospital/ patient numbers

And current revenues

The numbers of hospitals and patients will increase enormously over next couple of years , and revenues will rise hugely accordingly

Just need to look at the latest webinar presentation and it is very exciting to read

Apologies if it came across that way

Davemk,

I am referring to this with my comment

Phase 3 preparation activities having completed the majority of the preparation in 2023. We are targeting to commence our Phase 3 clinical trial in H2 2024. In 2023, we substantially completed the development of our 2nd Generation Nasal Illuminator, and we are preparing for its commercial launch in 2024.

The FDA approval is a game changing and allows access into the massive US market

The technology is already approved in other countries and being used

The stockpile of evidence is already in place

Ppl should be loading up sub 10p